Dosage - Creative Biolabs

Animal	Route of administration	Dosage	Volume of injection	The interval between injection	After how many hours or days	Targeted macrophages
		0.2 mg/ml				microglial cells
	Intravenous injection	100 µl/10 g body weight			24 hours	Spleens
canine MH cells	In vitro experiment	1, 2.5, or 5% v/v			72 hours later	Splenic macrophages (spleen)
CG3 cells (Thyroid cancer cells)	In vitro experiment					CG3 cells (Thyroid cancer cells) (in vitro)
Chickens	Intravenous injection		0.3 ml	six days before inoclulation with RB -1B	on days 7 and 21 after the challenge	spleen
Dogs	Intravenous injection	0.5 ml/kg		once in 2 weeks later in four dogs and a third dog received atotal of three infusions administered at 2-week intervals	first 24 h	macrophages that was sufficient to block destruction of opsonizederythrocytes in vivo
dogs	intravenous injection	0.5 ml/kg				Spleen
Female gerbils	intravenous injection		0.6 ml		5 days after treatment	Cerebro spinal fluid (CSF)
Female mice			40 µl		at 24, 48 or 72 h	peritoneal macrophages
Female mice	Intravenous injection			on days 1, 3, and 5 after infection		brain sections
Female mice	Intravenous injection				after 3 days	spleen
Female mice	Intravenous injection				at days 3 and 7 after treatment	Spleen
Female mice	intravenous injection			2 days prior to the intravenous injection with DNP-BSA	within 24 h and maintain their depletion for approximately 1 week	Liver (kupffer cells)
Female mice	Intravenous injection		0.1 ml	48 h prior to treatment with APAP.	After 48 hours	Liver
Female mice	intravenous injection		0.1 ml	4–6 h before elicitation of anaphylaxis		spleens
Female mice	intravenous injection		0.1 ml	2 days before BMT		Liver and Spleen
Female mice	Intravenous injection		0.1 ml for inflammation studies		48 hours	Liver and spleen
Female mice	Intravenous injection		0.1 ml for iron studies	Injection once every 5 days (a total of four injections during the diet period).	24 hours	Liver and spleen
Female mice	Intravenous injection		0.2 ml		within 24 hours	Liver and Spleen
Female mice	intravenous injection		0.2 ml	2 days prior to challenge		spleen and liver